News Detail
![](pdf/fda_maha260624080917.jpg)
Mumbai, 26 June 2024: An inquiry has been demanded and a question was raised in the Maharashtra Legislative Assembly related to export permissions granted without proper stability testing for over 200 pharma companies in the state of Maharashtra.
This issue, which has ......
View Details
Source : Pharmabiz
Maharashtra Legislative Assembly
stability testing
Abhay Pandey
AFDLHF
drug testing standards
Maharashtra FDA
International Council for Harmonisation
ICH
WHO
Related News
- Orchid Pharma partners with Cipla to launch antibiotic Cefepime-Enmetazobactam in India (28-06-2024)
- DCA Telangana seizes spurious drug Vertin Tabs, overpriced Itragril-200 Caps and 3 drugs for misleading claims (28-06-2024)
- Govt sanctions ₹700 crore for setting up pharma and med tech centres (28-06-2024)
- GB Nagar: Himachal drug makers booked for sub-standard medicines (28-06-2024)
- CDSCO cracks whip on drug manufacturing units over quality lapses (28-06-2024)
- Madras HC sets aside Ban on online Sale of Medicines (28-06-2024)
- DCA Telangana seized 3 overpriced medicines and Two with misleading claims (27-06-2024)
- Centre puts in abeyance order linking CGHS with ABHA (27-06-2024)
- AFDLHF raises alarm over fake websites exploiting food licence seekers (27-06-2024)
- US FDA recommends steps to improve diversity in clinical trials (27-06-2024)